Resumen

GOMEZ-ALMAGUER, David; HERRERA-ROJAS, Miguel; OLIVARES-GAZCA, Juan Carlos  y  RUIZ-ARGUELLES, Guillermo J.. Hematopoietic stem cell transplantation (HSCT) in the COVID-19 pandemic era. Gac. Méd. Méx [online]. 2021, vol.157, suppl.3, pp.S148-S150.  Epub 25-Abr-2022. ISSN 2696-1288.  https://doi.org/10.24875/gmm.m21000473.

The pandemic of coronavirus infectious disease-2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a threat to global health. This has become an obstacle for the practice of hematology, mostly in low-middle income countries. For those hematologist and oncologists who perform hematopoietic stem cell transplantation HSCT the usual challenges of this kind of medical procedures have increased because of the COVID-19 pandemic. The importance of find the best route for performing HSCT avoiding excessive COVID-19 risk is of great importance. By doing so, we have been able to conduct 170 hematopoieic stem cell transplants during the COVID-19 pandemia.

Palabras llave : COVID-19; SARS-CoV-2; Stem cell; Transplants; Transplantation.

        · resumen en Español     · texto en Inglés     · Inglés ( pdf )